Skip to main content

Raise Your Profile

Whether you are looking to attract a new business client, investment and partnering deal flow or talent, among other goals, One Nucleus offers a wide range of opportunities to raise your profile to our members and to the Greater Cambridge cluster in particular.
Raise Your Profile
  • Discounts for Members

    Discounts for Members

    Members can take advantage of discounts on a wide range of products and services to maximise their return on the member subscription, often recovering multiples of the fees paid. Receive discounted rates on laboratory supplies, services, key industry events and more.
    Learn more
  • Connect with Our Network

    Connect with Our Network

    A key advantage to any company joining One Nucleus is the ability to connect to potential partners, investors, service providers, clients and their peers for knowledge-sharing. We do this through our varied range of informative networking events, which tend to be situated throughout Cambridge and London.
    Learn more
  • Build the Best Teams

    Build the Best Teams

    One Nucleus recognises that a company’s employees are its most valuable asset and the competition for talented and skilled employees has never been fiercer in the region’s life science sector. One Nucleus offers a range of services and engagement opportunities in this critical area to help support our members.
    Learn more

Events

Connecting and meeting with business partners, fellow innovators and key advisers is a vital part of everyone's endeavours since it enables knowledge exchange and onward contact for mutual and collective success. Complementing the wider One Nucleus support activities our portfolio of events is designed to meet the needs of our network in terms of content, format, timing, peer-to-peer engagements and modes of delivery.
  • Events
  • Events
  • Events
  • Events

Membership Overview

With Gold and Silver membership options, our 400 company members and their staff can benefit from a wide variety of savings, profiling opportunities, and more.
  • Membership

About One Nucleus

One Nucleus is a not-for-profit Life Sciences & Healthcare membership organisation headquartered in Cambridge. We support institutions, companies and individuals in the Life Sciences sector providing local, UK-wide and international connectivity. 
  • About

Be part of the next Discovery Spark cohort – Applications closing soon!

Discovery Spark is a transformative innovation growth programme for early-stage companies, packed with invaluable resources and support. Across a number of in-person sessions led by seasoned professionals and industry leaders, participants will gain the essential skills needed to lay robust foundations in their business and prepare for investment. Discovery Spark is aimed at businesses across a diverse range of sectors including biotech, medtech, diagnostics and advanced therapies and those who have raised up to £1 million in equity.

CDD European Life Science Community Meeting

Collaborative Drug Discovery Community Meeting brings the European technology and scientific communities together. This year is special as we are celebrating CDD's 20 years of excellence.

We invite you to join us to learn about the latest life science industry trends, discuss research data strategies on best practices with peers, explore CDD Vault, get personalized training, listen to engaging keynotes, and network with industry experts. 

The distinguished line-up of speakers include:

PhoreMost extends Series B financing to $50M to advance high-value oncology and inflammation degrader programmes

  • Investment to enable progression of pipeline of novel degrader assets through pre-clinical development and support further development of GlueSEEKER™ platform
  • Led by Parkwalk Advisors alongside existing investors BGF, Dr Jonathan Milner, Amadeus Capital and Astellas Venture Management

NanoSyrinx closes c. £10 million GBP financing and appoints Dr. Edwin Moses as Chairman

  • Round co-led by BGF, Octopus Ventures and M Ventures, with support from new corporate investor, Eli Lilly and Company, and existing investors, IQ Capital and Meltwind
  • Appointment of Edwin Moses as Chairman to support the leadership team in maximising the value of the technology platform
  • Novel “nanosyringe” platform can deliver complex biologic payloads selectively and intracellularly, unlocking the interior of the cell for new intervention possibilities in unmet medical needs

Pioneer Group and Novo Nordisk team up on Golden Ticket Programme for cardiometabolic health innovations

Pioneer Group, a specialist in life science infrastructure and venture building, has
teamed up with global healthcare company Novo Nordisk to launch a Golden
Ticket designed to help accelerate innovations in cardiometabolic diseases, rare
blood and rare endocrine disorders.

The Golden Ticket programme is aimed at early-stage biotech companies focused
on novel drug targets and transformational medicines in cardiometabolic disease,
with robust research plans and potential for successful research development.

Tailor made transduction-ready viral particles

AMSBIO offers a production service for high quality custom transduction-ready viral particles designed to support your research and save you valuable time.

Drawing upon extensive knowledge in research areas including Adeno Associated Virus, Adenovirus, Herpes Simplex Virus, Lentivirus, MMLV Retrovirus and more - AMSBIO viral services include the design and construction of the vectors, ultimately providing you with high quality viral particles that you can rely on.

PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study

MetX funded by $1M grant from Metrodora Foundation to accelerate research for complex multisystem disorders

SALT LAKE CITY, UT and OXFORD, UK – 18 September 2024 – PrecisionLife, a leading clinical-stage precision medicine company focused on chronic diseases, and Metrodora Institute, an advanced US research and healthcare center, have begun sharing the first research results with participants from Metrodora’s MetX study.

Gene-environment interactions in human health and disease

This introductory course explores the complex interplay between genes and the environment in shaping human phenotypes. Participants will gain knowledge of cohort datasets, environmental readouts, and computational resources to investigate gene-environment interactions. Ethical and legal frameworks related to data privacy and consent will be discussed. The course also covers computational modelling techniques for integrating genotype and environmental effects. By the end, attendees will be equipped to analyse cohort datasets, make use of computational resources, and interpret the results.

Subscribe to